Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 May:94:44-48.
doi: 10.1016/j.ijid.2020.03.004. Epub 2020 Mar 12.

The SARS-CoV-2 outbreak: What we know

Di Wu  1 , Tiantian Wu  2 , Qun Liu  3 , Zhicong Yang  4
Affiliations
Review

The SARS-CoV-2 outbreak: What we know

Di Wu et al. Int J Infect Dis. 2020 May.

Abstract

There is a current worldwide outbreak of the novel coronavirus Covid-19 (coronavirus disease 2019; the pathogen called SARS-CoV-2; previously 2019-nCoV), which originated from Wuhan in China and has now spread to 6 continents including 66 countries, as of 24:00 on March 2, 2020. Governments are under increased pressure to stop the outbreak from spiraling into a global health emergency. At this stage, preparedness, transparency, and sharing of information are crucial to risk assessments and beginning outbreak control activities. This information should include reports from outbreak site and from laboratories supporting the investigation. This paper aggregates and consolidates the epidemiology, clinical manifestations, diagnosis, treatments and preventions of this new type of coronavirus.

Keywords: Clinical features; CoVID-19; Coronavirus; Diagnosis; Epidemiology; Managements strategies; SARS-CoV-2; Treatments.

PubMed Disclaimer

References

    1. Weiss S.R., Leibowitz J.L. Coronavirus pathogenesis. Adv Virus Res. 2011;81:85–164. - PMC - PubMed
    1. CCTV.COM A 30-hour old infant in Wuhan diagnosed and mother-to-child infection suspected. http://m.news.cctv.com/2020/02/05/ARTIywVxQICUUURSIWzSzvkf200205.shtml Available at:
    1. Arabi Y.M., Alothman A., Balkhy H.H. Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-beta1b (MIRACLE trial): study protocol for a randomized controlled trial. Trials. 2018;19:81. - PMC - PubMed
    1. Arabi Y.M., Mandourah Y., Al-Hameed F., Sindi A.A., Mekhlafi G.A.A. Corticosteroid therapy for critically Ill patients with Middle East respiratory syndrome. Am J Respir Crit Care Med. 2020;197:757–767. - PubMed
    1. Bauch C.T., Lloyd-Smith J.O., Coffee M.P., Galvani A.P. Dynamically modeling SARS and other newly emerging respiratory illnesses past, present, and future. Epidemiology. 2005;16:791–801. - PubMed